Lien vers Pubmed [PMID] – 23979730
Lien DOI – 10.1128/AAC.00416-13
Antimicrob Agents Chemother 2013 Nov; 57(11): 5727-8
Iatrogenic Cushing’s syndrome is an undesirable outcome of glucocorticoids treatment. It can be increased by pharmacologic interactions. Glucocorticoid therapy, given in association with ritonavir, and some azole treatments are causes of iatrogenic Cushing’s syndrome. We present a patient with common-variable immunodeficiency who received 7 years of itraconazole therapy for bronchial colonization with Aspergillus in combination with inhaled fluticasone without any Cushingoid symptoms. After a switch to posaconazole, the patient developed Cushingoid symptoms.